Abstract

The investigation of central nervous system vascular changes in the pathophysiology of multiple sclerosis (MS) is a time-honored concept. Yet, recent reports on changes in venous cerebrospinal outflow, the advent of new magnetic resonance imaging techniques and the investigation of immunomodulatory properties of several vascular mediators on the molecular level have added new excitement to hypotheses centering around vascular pathology as determining factor in the pathophysiology of MS. Here we critically review the concept of chronic cerebrospinal venous insufficiency in MS patients and describe new imaging techniques including perfusion weighted imaging, susceptibility weighted imaging and diffusion weighted imaging which reveal central nervous system hypoperfusion, perivascular iron deposition and diffuse structural changes in the MS brain. On a molecular basis, vascular mediators represent interesting targets connecting vascular pathology with immunomodulation. In summary, the relation of venous changes to the pathophysiology of MS may not be as simple as initially described and it certainly seems awkward to think of the complex disease MS solely as result of a simple venous outflow obstruction. Yet, the investigation of new vascular concepts as one variable in the pathophysiology of the autoimmune attack seems very worthwhile and may add to a better understanding of this devastating disorder.

Highlights

  • The investigation of central nervous system vascular changes in the pathophysiology of multiple sclerosis (MS) is a time-honored concept

  • The starting point: Cerebrospinal venous insufficiency in multiple sclerosis? Chronic cerebrospinal venous insufficiency (CCSVI) describes a vascular condition characterized by anomalies of the main extra-cranial cerebrospinal veins that interfere with normal cerebrospinal outflow [1]

  • CCSVI has recently been reported at a high prevalence in multiple sclerosis (MS) patients and proposed as a pathogenic factor challenging the autoimmune hypothesis of the disease [1,5,6]

Read more

Summary

Introduction

The investigation of central nervous system vascular changes in the pathophysiology of multiple sclerosis (MS) is a time-honored concept. CCSVI has recently been reported at a high prevalence in multiple sclerosis (MS) patients and proposed as a pathogenic factor challenging the autoimmune hypothesis of the disease [1,5,6]. This finding was confirmed by another study of the same group who detected CCSVI in all of 109 MS subjects but none of the 177 controls (sensitivity 100%, specificity 100%) [6].

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.